These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31808354)

  • 1. Visual Hallucinations and Impaired Conscious Visual Perception in Parkinson Disease.
    Kurita A; Koshikawa H; Akiba T; Seki K; Ishikawa H; Suzuki M
    J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):377-385. PubMed ID: 31808354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; de Jong BM; Renken R; Leenders KL; Cornelissen FW; van Laar T
    Brain; 2009 Nov; 132(Pt 11):2980-93. PubMed ID: 19755518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 2A receptors and visual hallucinations in Parkinson disease.
    Ballanger B; Strafella AP; van Eimeren T; Zurowski M; Rusjan PM; Houle S; Fox SH
    Arch Neurol; 2010 Apr; 67(4):416-21. PubMed ID: 20385906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations.
    Oishi N; Udaka F; Kameyama M; Sawamoto N; Hashikawa K; Fukuyama H
    Neurology; 2005 Dec; 65(11):1708-15. PubMed ID: 16344511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies.
    Kurita A; Murakami M; Takagi S; Matsushima M; Suzuki M
    Mov Disord; 2010 Jan; 25(2):167-71. PubMed ID: 20063433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention and visual dysfunction in Parkinson's disease.
    Botha H; Carr J
    Parkinsonism Relat Disord; 2012 Jul; 18(6):742-7. PubMed ID: 22503538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
    Uchiyama M; Nishio Y; Yokoi K; Hosokai Y; Takeda A; Mori E
    Parkinsonism Relat Disord; 2015 Jun; 21(6):603-9. PubMed ID: 25864093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic alterations in patients with Parkinson disease and visual hallucinations.
    Boecker H; Ceballos-Baumann AO; Volk D; Conrad B; Forstl H; Haussermann P
    Arch Neurol; 2007 Jul; 64(7):984-8. PubMed ID: 17620488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.
    Geerligs L; Meppelink AM; Brouwer WH; van Laar T
    Clin Neuropharmacol; 2009; 32(5):266-8. PubMed ID: 19667979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cortical visual processing in PD with hallucinations: an fMRI study.
    Stebbins GT; Goetz CG; Carrillo MC; Bangen KJ; Turner DA; Glover GH; Gabrieli JD
    Neurology; 2004 Oct; 63(8):1409-16. PubMed ID: 15505157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease.
    Sinclair L; Brenton J; Liu AKL; MacLachlan R; Gentleman SM; Love S
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):168-176. PubMed ID: 34961331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hallucinations and conscious access to visual inputs in Parkinson's disease.
    Lefebvre S; Baille G; Jardri R; Plomhause L; Szaffarczyk S; Defebvre L; Thomas P; Delmaire C; Pins D; Dujardin K
    Sci Rep; 2016 Nov; 6():36284. PubMed ID: 27841268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Junqué C; Martí MJ; Valldeoriola F; Tolosa E
    Mov Disord; 2006 Sep; 21(9):1483-7. PubMed ID: 16705661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impairment in visual cognition in patients with Parkinson disease].
    Hirayama K; Ishioka T
    Brain Nerve; 2007 Sep; 59(9):923-32. PubMed ID: 17886474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT study.
    Kiferle L; Ceravolo R; Giuntini M; Linsalata G; Puccini G; Volterrani D; Bonuccelli U
    Parkinsonism Relat Disord; 2014 Jul; 20(7):761-5. PubMed ID: 24787757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Categorising Visual Hallucinations in Early Parkinson's Disease.
    Clegg BJ; Duncan GW; Khoo TK; Barker RA; Burn DJ; Yarnall AJ; Lawson RA
    J Parkinsons Dis; 2018; 8(3):447-453. PubMed ID: 30040741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral geniculate atrophy in Parkinson's with visual hallucination: A trans-synaptic degeneration?
    Lee JY; Yoon EJ; Lee WW; Kim YK; Lee JY; Jeon B
    Mov Disord; 2016 Apr; 31(4):547-54. PubMed ID: 26846525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral atrophy in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Martí MJ; Tolosa E; Giménez M; Bargalló N; Valldeoriola F; Junqué C
    Eur J Neurol; 2007 Jul; 14(7):750-6. PubMed ID: 17594330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.